Xenoscience Inc.
Phoenix, Arizona, United States
Neurologist in Phoenix, Arizona
2601 N 3rd St #125, Phoenix, AZ 85004
About Xenoscience Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Xenoscience Inc.
During the past decade, Xenoscience Inc. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
2008-01-01
2009-09-01
Completed
181
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off
2008-03-01
2009-05-01
Terminated
14
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
2008-05-01
2011-01-01
Completed
389
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
2008-04-01
2010-08-01
Terminated
50
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
2008-01-01
2010-12-01
Completed
103
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
2009-04-01
2013-05-01
Completed
193
Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System
2009-05-01
2009-06-01
Completed
49
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
2013-11-01
2018-01-01
Terminated
13
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Xenoscience Inc." #1 sponsor was "Allergan" with 2 trials, followed by "Biogen" with 2 trials
sponsored, "Celgene" with 2 trials sponsored, "Chelsea Therapeutics" with 2 trials sponsored and "Navidea Biopharmaceuticals"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Xenoscience Inc."
#1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator, "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Xenoscience Inc.
According to Clinical.Site data, the most researched conditions in "Xenoscience Inc." are
"Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Migraine, With or Without Aura" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Xenoscience Inc." in a lesser frequency.
Clinical Trials Intervention Types at Xenoscience Inc.
Most popular intervention types in "Xenoscience Inc." are "Drug" (25 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Droxidopa" (2 trials), "NAV5001" (2 trials), "Placebo-matching Ubrogepant" (2 trials) and "Ubrogepant" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Xenoscience Inc.
The vast majority of trials in "Xenoscience Inc." are
25 trials for "All" genders.
Clinical Trials Status at Xenoscience Inc.
Currently, there are NaN active trials in "Xenoscience Inc.".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Xenoscience Inc.,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Xenoscience Inc., 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".